Roedl Kevin, Jarczak Dominik, Blohm Rasmus, Winterland Sarah, Müller Jakob, Fuhrmann Valentin, Westermann Dirk, Söffker Gerold, Kluge Stefan
Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
Department of Intensive Care Medicine, University Medical Center Hamburg-Eppendorf, Hamburg, Germany; Tabea Hospital Hamburg, Hamburg, Germany.
Resuscitation. 2020 Nov;156:92-98. doi: 10.1016/j.resuscitation.2020.09.003. Epub 2020 Sep 10.
Critically ill patients in intensive care units can frequently suffer from cardiac arrest (ICU-CA), the incidence of ICU-CA is associated with high mortality. Most studies on ICU-CA focused on risk factors and intra-arrest determinants. However, there is a lack of data on organ failure after ICU-CA and its clinical implications for outcome. This study aimed to investigate ICU-CA incidence, outcome and the occurrence of organ failure after ICU-CA.
We conducted a prospective observational study over a 1-year at 12 intensive care units of a tertiary care university hospital. We included all consecutive adult patients suffering cardiac arrest (CA) during the ICU stay. Incidence, clinical and neurological outcome, as well as organ failure and support were assessed.
Out of 7690 patients, 176 (2%) with ICU-CA were identified during the study period. Male patients comprised 63% and the median age was 70 (58-78) years. The median ICU stay before ICU-CA was 3 (1-8) days. The initial cardiac rhythm was shockable (VT/VF) in 23% of patients; defibrillation during CPR was performed in 19%. The presumed cause of CA was cardiac in 24%, and sustained ROSC was observed in 80% of patients. Before CA 57% (n = 100) of patients were sedated, 63% (n = 110) mechanically ventilated, 70% needed vasopressor therapy and renal replacement therapy was necessary in 27% (n = 48) of patients. Organ failure after ICU-CA was common, 70% suffered from post-CA cardiac failure, renal replacement therapy was newly initiated in 26% of patients and liver failure occurred in 24% of patients. Mortality at ICU-discharge and at hospital discharge was 66 % and 68 %, respectively. Multivariate regression analysis identified the SOFA score [HR 1.09, 95% CI (0.92-3.18); p < 0.05] and liver failure [HR 2.44, 95% CI (1.39-4.26); p < 0.001] after ICU-CA as independent predictors of mortality.
The incidence of ICU-CA is rare in critically ill patients. Organ failure before and after ICU-CA is common; liver failure incidence and severity of illness after ICU-CA are independent predictors of mortality and should be considered in further decisions on ICU therapy.
重症监护病房(ICU)中的重症患者经常会发生心脏骤停(ICU-CA),ICU-CA的发生率与高死亡率相关。大多数关于ICU-CA的研究都集中在危险因素和心脏骤停期间的决定因素上。然而,关于ICU-CA后器官衰竭及其对预后的临床影响的数据却很缺乏。本研究旨在调查ICU-CA的发生率、预后以及ICU-CA后器官衰竭的发生情况。
我们在一家三级护理大学医院的12个重症监护病房进行了为期1年的前瞻性观察研究。我们纳入了所有在ICU住院期间连续发生心脏骤停(CA)的成年患者。评估了发生率、临床和神经学预后以及器官衰竭和支持情况。
在7690例患者中,研究期间确定了176例(2%)发生ICU-CA。男性患者占63%,中位年龄为70(58-78)岁。ICU-CA前的中位ICU住院时间为3(1-8)天。23%的患者初始心律为可电击心律(室性心动过速/心室颤动);心肺复苏期间进行除颤的患者占19%。CA的推测原因是心脏原因的占24%,80%的患者观察到持续自主循环恢复(ROSC)。CA前,57%(n = 100)的患者接受了镇静,63%(n = 110)的患者接受了机械通气,70%的患者需要血管升压药治疗,27%(n = 48)的患者需要进行肾脏替代治疗。ICU-CA后器官衰竭很常见,70%的患者发生CA后心力衰竭,26%的患者新开始进行肾脏替代治疗,24%的患者发生肝功能衰竭。ICU出院时和医院出院时的死亡率分别为66%和68%。多因素回归分析确定ICU-CA后的序贯器官衰竭评估(SOFA)评分[风险比(HR)1.09,95%置信区间(CI)(0.92-3.18);p < 0.